Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

about

Cholesterol Efflux: Does It Contribute to Aortic Stiffening?

P2860

Q53688278-6035D382-152D-49B5-913C-CC1EC2290F43

P2860

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

Item

http://www.wikidata.org/entity/Q41389933

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Analysis of Serum Cholesterol ...... of Nonischemic Heart Failure.

@en

type

Item

label

Analysis of Serum Cholesterol ...... of Nonischemic Heart Failure.

@en

prefLabel

Analysis of Serum Cholesterol ...... of Nonischemic Heart Failure.

@en

P1476

Analysis of Serum Cholesterol ...... of Nonischemic Heart Failure.

@en

P2093

Beatrice Dal Pino

http://www.w3.org/2001/XMLSchema#string

Elda Favari

http://www.w3.org/2001/XMLSchema#string

Fabio A Recchia

http://www.w3.org/2001/XMLSchema#string

Federico Bigazzi

http://www.w3.org/2001/XMLSchema#string

Francesco Sbrana

http://www.w3.org/2001/XMLSchema#string

Franco Bernini

http://www.w3.org/2001/XMLSchema#string

Maria Pia Adorni

http://www.w3.org/2001/XMLSchema#string

Mariarita Puntoni

http://www.w3.org/2001/XMLSchema#string

Tiziana Sampietro

http://www.w3.org/2001/XMLSchema#string

P2860

ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis

Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I

Myocardial lipid metabolism in compensated and advanced stages of heart failure: evaluation by canine pacing model with BMIPP.

Cell cholesterol efflux: integration of old and new observations provides new insights.

Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure.

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

HDL cholesterol efflux capacity and incident cardiovascular events.

Importance of different pathways of cellular cholesterol efflux.

Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia.

P304

853-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5551/JAT.37101

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Lionetti

P577

2016-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27980243

http://www.w3.org/2001/XMLSchema#string

P932

5556192

http://www.w3.org/2001/XMLSchema#string

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

about

P2860

P2860

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932